Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...
Pressroom
Recent Press Releases
New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets
NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new...
2019 Lupus Luminary Luncheon for Science Celebrates Women of Achievement for Lupus Awareness Month
NEW YORK, NY – May 7, 2019. The 10th annual Lupus Luminary Luncheon for Science honored the accomplishments of...
Lupus Research Alliance Kicks Off Lupus Awareness Month with “Breaking through for Lupus Research: 20 Years of Progress”
NEW YORK, NY. May 1 — The Lupus Research Alliance (LRA) launches its Breaking through for Lupus Research: 20...
Lupus Kidney Inflammation May Have Different Cause Than Commonly Believed
NEW YORK, NY. April 29. Lupus can harm many organs in the body, including the kidneys. A new study...
Lupus Research Alliance Earns Coveted 4-Star Rating from Charity Navigator
NEW YORK, NY. March 28 – Lupus Research Alliance earned a 4-star rating from Charity Navigator, America’s largest independent...
Lupus Research Alliance Advocates Call on Congress to Fund More Lupus Scientific Exploration
WASHINGTON, DC – March 19. Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, celebrates its...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success
February 28, 2019
NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...
Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease...
Lupus Therapeutics Launches Peer Training Program to Help Patients Benefit from Clinical Trials
NEW YORK, NY. February 1, 2019. Lupus Research Alliance clinical affiliate Lupus Therapeutics launched the Patient Advocates for Lupus Studies...
Lupus Research Alliance and Lupus Therapeutics Partner on New Phase 3 Trial Testing Potential Benefit of Ustekinumab (Stelara®) in Lupus
The Lupus Research Alliance announced that clinical research affiliate Lupus Therapeutics is partnering with the pharmaceutical company, Janssen, to...